JP2017509692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509692A5 JP2017509692A5 JP2016566866A JP2016566866A JP2017509692A5 JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5 JP 2016566866 A JP2016566866 A JP 2016566866A JP 2016566866 A JP2016566866 A JP 2016566866A JP 2017509692 A5 JP2017509692 A5 JP 2017509692A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- patient
- dpp4
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931878P | 2014-01-27 | 2014-01-27 | |
| US61/931,878 | 2014-01-27 | ||
| US201461990932P | 2014-05-09 | 2014-05-09 | |
| US61/990,932 | 2014-05-09 | ||
| PCT/US2015/012885 WO2015112970A1 (en) | 2014-01-27 | 2015-01-26 | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017509692A JP2017509692A (ja) | 2017-04-06 |
| JP2017509692A5 true JP2017509692A5 (enExample) | 2018-03-08 |
Family
ID=53682019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566866A Pending JP2017509692A (ja) | 2014-01-27 | 2015-01-26 | 喘息肺におけるｉｌ−１３活性化の末梢バイオマーカーとしてのジペプチジルペプチターゼ４（ｄｐｐ４／ｃｄ２６） |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20160363591A1 (enExample) |
| EP (2) | EP3685857A1 (enExample) |
| JP (1) | JP2017509692A (enExample) |
| KR (1) | KR20160113700A (enExample) |
| CN (1) | CN105934254A (enExample) |
| AU (1) | AU2015209124A1 (enExample) |
| BR (1) | BR112016017192A2 (enExample) |
| CA (1) | CA2937387A1 (enExample) |
| MX (1) | MX2016009491A (enExample) |
| RU (1) | RU2016134838A (enExample) |
| SG (1) | SG11201606102UA (enExample) |
| WO (1) | WO2015112970A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HK1232290A1 (zh) * | 2014-02-07 | 2018-01-05 | Medimmune, Llc | 检测人类骨膜蛋白的新型测定 |
| AU2016205188A1 (en) | 2015-01-09 | 2017-06-22 | Medimmune, Llc | Assay to detect human DPP-4 |
| EP3371225A2 (en) * | 2015-11-04 | 2018-09-12 | AstraZeneca AB | Dipeptidyl peptidase-4 and periostin as predictors of clinical response to eosinophil-targeted therapeutic agents in eosinophilic diseases |
| JP6871948B2 (ja) | 2016-04-27 | 2021-05-19 | アッヴィ・インコーポレイテッド | 抗ｉｌ−１３抗体を使用する、ｉｌ−１３活性が有害である疾患の治療方法 |
| CN113372446A (zh) | 2016-06-08 | 2021-09-10 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| PT3528838T (pt) * | 2016-09-23 | 2023-09-04 | Hoffmann La Roche | Utilizações de antagonistas de il-13 para tratamento de dermatite atópica |
| US10386368B2 (en) | 2017-02-24 | 2019-08-20 | Trustees Of Boston University | Isolation of human lung progenitors derived from pluripotent stem cells |
| CN109055522A (zh) * | 2018-07-03 | 2018-12-21 | 吉林大学 | C4orf38在制备用于检测或治疗神经性疼痛的产品中的应用 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN113155996A (zh) * | 2021-03-23 | 2021-07-23 | 广州医科大学附属第一医院（广州呼吸中心） | 15(s)-羟基二十碳四烯酸在评估变应原特异性免疫治疗效果中的应用 |
| EP4540284A2 (en) | 2022-06-17 | 2025-04-23 | Apogee Therapeutics, Inc. | Antibodies that bind interleukin 13 and methods of use |
| CN117607452A (zh) * | 2022-09-23 | 2024-02-27 | 上海市第十人民医院 | 蛋白生物标志物gbp1在克罗恩病临床诊断中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| WO2004104216A2 (en) * | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| EP1723257B1 (en) * | 2004-02-23 | 2019-01-09 | Erasmus University Medical Center Rotterdam | Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling |
| BRPI0720280A2 (pt) * | 2006-12-11 | 2014-01-28 | Wyeth Corp | Métodos e composições para tratar e monitorar tratamento de desordens associadas à il-13 |
| US20090155784A1 (en) * | 2007-01-22 | 2009-06-18 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
| US20120005206A1 (en) * | 2007-02-09 | 2012-01-05 | Konstantinos Anagnostakis | Apparatus and method for analysis of data traffic |
| AU2008316313B2 (en) * | 2007-10-23 | 2015-04-16 | Clinical Genomics Pty. Ltd. | A method of diagnosing neoplasms - II |
| BRPI0906261A2 (pt) | 2008-03-31 | 2015-07-07 | Genentech Inc | "métodos de diagnóstico de um subtipo de asma em uma amostra de paciente, usos de um agente terapêutico e kits de diagnóstico de um subtipo de asma em uma amostra de paciente" |
| US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
| WO2012049278A1 (en) * | 2010-10-15 | 2012-04-19 | Medimmune Limited | Therapies for improving pulmonary function |
| RU2578468C2 (ru) | 2010-12-16 | 2016-03-27 | Дженентек, Инк. | Способы диагностики и лечения, связанные с ингибированием th2 |
| WO2012158954A1 (en) | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
-
2015
- 2015-01-26 CA CA2937387A patent/CA2937387A1/en not_active Abandoned
- 2015-01-26 SG SG11201606102UA patent/SG11201606102UA/en unknown
- 2015-01-26 WO PCT/US2015/012885 patent/WO2015112970A1/en not_active Ceased
- 2015-01-26 BR BR112016017192A patent/BR112016017192A2/pt not_active IP Right Cessation
- 2015-01-26 MX MX2016009491A patent/MX2016009491A/es unknown
- 2015-01-26 AU AU2015209124A patent/AU2015209124A1/en not_active Abandoned
- 2015-01-26 JP JP2016566866A patent/JP2017509692A/ja active Pending
- 2015-01-26 EP EP20158832.4A patent/EP3685857A1/en not_active Withdrawn
- 2015-01-26 KR KR1020167023637A patent/KR20160113700A/ko not_active Withdrawn
- 2015-01-26 CN CN201580005884.2A patent/CN105934254A/zh active Pending
- 2015-01-26 RU RU2016134838A patent/RU2016134838A/ru not_active Application Discontinuation
- 2015-01-26 EP EP15740660.4A patent/EP3099323A4/en not_active Withdrawn
- 2015-01-26 US US15/114,467 patent/US20160363591A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017509692A5 (enExample) | ||
| Cao et al. | Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A | |
| O'Byrne et al. | Asthma progression and mortality: the role of inhaled corticosteroids | |
| RU2016134838A (ru) | Дипептидил пептидаза-4 (dpp4/cd26) как периферический биомаркер активации il-13 в астматическом легком | |
| Jonstam et al. | Dupilumab reduces local type 2 pro‐inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis | |
| Buhl et al. | Severe eosinophilic asthma: a roadmap to consensus | |
| JP6457463B2 (ja) | 処置方法 | |
| Opina et al. | Phenotype-driven therapeutics in severe asthma | |
| EP2627673B1 (en) | Therapies for improving pulmonary function | |
| JP2018533557A5 (enExample) | ||
| CN107073114B (zh) | 使用瑞利珠单抗治疗中度到重度嗜酸细胞性哮喘 | |
| Hvidtfeldt et al. | Airway hyperresponsiveness reflects corticosteroid-sensitive mast cell involvement across asthma phenotypes | |
| JP2017036296A (ja) | 抗ｉｌ−５抗体を投与するための方法 | |
| Sposato et al. | Effects of omalizumab in severe asthmatics across ages: a real life Italian experience | |
| Yilmaz et al. | Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilicasthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study | |
| Tagaya et al. | Effect of tiotropium on mucus hypersecretion and airway clearance in patients with COPD | |
| KR20240049348A (ko) | 항-인터루킨-33 항체를 사용한 만성 폐쇄성 폐질환의 치료 | |
| Pavord et al. | Emerging biologics in severe asthma | |
| Li | Targeting the IL-4/IL-4R Axis in Th2 Inflammatory Diseases: A Review of Clinical Efficacy and Safety | |
| Benton et al. | Year in review 2017: Chronic obstructive pulmonary disease and asthma. | |
| US11224653B2 (en) | Treatment strategy for non-responders to 100MG subcutaneous mepolizumab | |
| Rupani et al. | Eosinophilic asthma | |
| Mastalerz et al. | Effect of inhaled corticosteroids on small airway inflammation in patients with bronchial asthma | |
| Moslem et al. | Evaluation of Effectiveness of Dexamethasone versus Hydrocortisone in Reducing Hospital Length, Peak Expiratory Flow, Oxidative Stress Factors and Inflammatory Mediators in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Patients: A Randomized Controlled Trial | |
| MOELAMSYAH et al. | Late-Onset Asthma: A Review |